Literature DB >> 26334654

High prevalence of occult hepatitis B infection in an African urban population.

Betty S Apica1, Emmanuel Seremba1, Jody Rule2, He-Jun Yuan2, William M Lee2.   

Abstract

Occult hepatitis B infection (OBI), the presence of low hepatitis B virus (HBV) deoxyribonucleic acid (DNA) levels in patients without detectable hepatitis B surface antigen (HBsAg), has significant implications for understanding the natural history of hepatitis B infection. We determined the prevalence of OBI in African patients using a sensitive polymerase chain reaction (PCR) assay and describe here the characteristics of OBI in an urban African hospital population. Routine serological testing as well as molecular studies were performed on sera from 314 patients who were part of a previous study from an urban hospital emergency room in Kampala, Uganda, detecting HBV DNA using a nested PCR with amplification of two regions of the HBV genome. HBV viral loads (VL) were determined by real-time PCR (rtPCR) and sequencing performed to determine HBV genotype and S gene mutations. Among 314 subjects tested, 50 (16%) had chronic HBV infection, 94 (30%) had detectable HBV DNA despite testing HBsAg negative (OBI), and 170 (54%) were not infected. VLs of OBI subjects were relatively low although 19 (20%) had VL exceeding 10(4)  IU ml(-) . Subjects with chronic HBV infection had a higher median VL compared to OBI patients (P < 0.001). All chronic HBV sequenced (10) and 83/89 OBI sequences were genotype A, the remaining six being genotype D. S-gene mutations were present in some but not all OBI patients (48%). OBI is more prevalent among African patients than previously thought. This may have implications for clinical management and transfusion-related HBV transmission.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  hepatitis B; occult HBV infection; prevalence

Mesh:

Substances:

Year:  2015        PMID: 26334654     DOI: 10.1002/jmv.24372

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  [Prevalence of hepatitis B surface antigen and its associated factors in Senegalese military personnel sent on mission to Darfur].

Authors:  Moustapha Diop; Assane Diouf; Said Malaobé Seck; Gora Lo; Daye Ka; Aminata Massaly; Alassane Dieye; Ndeye Maguette Fall; Viviane Marie Pierre Cisse-Diallo; Khardiata Diallo-Mbaye; Ndèye Aissatou Lakhe; Louise Fortes-Déguénonvo; Cheikh Tidiane Ndour; Maserigne Soumaré; Moussa Seydi
Journal:  Pan Afr Med J       Date:  2017-03-15

Review 2.  [Occult hepatitis B reactivation in a patient with homozygous sickle cell disease: clinical case and literature review].

Authors:  Moustapha Diop; Viviane Marie Pierre Cisse-Diallo; Daye Ka; Ndèye Aissatou Lakhe; Khardiata Diallo-Mbaye; Aminata Massaly; Alassane Dièye; Ndèye Maguette Fall; Aboubacar Sadikh Badiane; Daouda Thioub; Louise Fortes-Déguénonvo; Gora Lo; Cheikh Tacko Diop; Cheikh Tidiane Ndour; Masserigne Soumaré; Moussa Seydi
Journal:  Pan Afr Med J       Date:  2017-10-10

3.  Twenty-Year Evolution of Hepatitis B Virus and Human Immunodeficiency Virus Prevalence and Incidence in Voluntary Blood Donors in Côte d'Ivoire.

Authors:  Benjamin Seri; Albert Minga; Delphine Gabillard; Bamori Dembele; Seidou Konate; Jérôme Le Carrou; Lambert Dohoun; Yao Abo; Sophie Karcher; Patrick Coffie; Thérèse N'Dri-Yoman; Alain Attia; Serge P Eholié; Christine Danel; Karine Lacombe; Xavier Anglaret; Anders Boyd
Journal:  Open Forum Infect Dis       Date:  2018-03-16       Impact factor: 3.835

4.  Prevalence and Clinical Significance of Occult Hepatitis B Infection in The Gambia, West Africa.

Authors:  Gibril Ndow; Amie Cessay; Damien Cohen; Yusuke Shimakawa; Mindy L Gore; Saydiba Tamba; Sumantra Ghosh; Bakary Sanneh; Ignatius Baldeh; Ramou Njie; Umberto D'Alessandro; Maimuna Mendy; Mark Thursz; Isabelle Chemin; Maud Lemoine
Journal:  J Infect Dis       Date:  2022-09-13       Impact factor: 7.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.